Biolife Solutions (BLFS) Long-Term Investments (2016 - 2026)

Biolife Solutions (BLFS) has 11 years of Long-Term Investments data on file, last reported at $30.5 million in Q1 2026.

• On a quarterly basis, Long-Term Investments rose 60.06% year-over-year to $30.5 million in Q1 2026; TTM through Mar 2026 was $30.5 million, a 60.06% increase from a year earlier, with the FY2025 full-year figure at $31.2 million, up 3040.7% from the prior year.
• Long-Term Investments for Q1 2026 stood at $30.5 million, down from $31.2 million in the prior quarter.
• Over the last five years, Long-Term Investments for BLFS reached as high as $31.2 million in Q4 2025 and fell as low as $489000.0 in Q2 2022.
• Historically, Long-Term Investments has averaged $8.3 million across 5 years, with a median of $1.8 million in 2023.
• Across the five-year window, Long-Term Investments tumbled 91.67% in 2022 and surged 3040.7% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $5.1 million in 2022, then plunged by 89.19% to $548000.0 in 2023, then jumped by 81.57% to $995000.0 in 2024, then jumped by 3040.7% to $31.2 million in 2025, then slipped by 2.4% to $30.5 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $30.5 million in Q1 2026, $31.2 million in Q4 2025, and $19.4 million in Q3 2025.